| Ytd | 44.33% | |
| 1y | 48.15% |
| Open | 3.03 | Prev Close | 3.00 | Low | 2.80 | High | 3.03 | Mkt Cap | 138.01M |
| Vol | 409.90K | Avg Vol | 2.56M | EPS | -0.27 | P/E | -10.37 | Forward P/E | -3.64 |
| Beta | 1.37 | Short Ratio | 0.54 | Inst. Own | 18.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.91 | 200-d Avg | 1.72 | 1yr Est | 10.00 |
ENTX News
U.S. Food and Drug Administration (FDA) Alignment on 12-Month Registrational Phase 3 Study to Suppor
TEL AVIV, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company
TEL AVIV, July 31, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company
MIAMI, July 29, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Entera Bio Ltd.
Entera Bio Ltd. (NASDAQ:ENTX) shares traded higher Wednesday after the company announced an oversubs
Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular
US stocks mixed in midday trading, Nasdaq falls 0.48%, Dow up 0.19%, S&P 500 down 0.23%. Consume
Dow Jones up 0.80% to 52,361.92, NASDAQ up 0.23% to 25,024.65, S&P 500 up 0.28% to 7,432.59. Com
The offering is led by existing investor BVF Partners L.P. Expected gross proceeds are anticipated t
ENTX stock jumps 35% in a month after the FDA backs a streamlined phase III plan for oral osteoporos
Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session
Entera Bio (NASDAQ: ENTX) may have just cleared its biggest regulatory hurdle yet. The FDA has provi
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 79.6% to $0.63 during Monday's regul
The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primar
EB612, a first-in-class long-acting PTH(1-34) oral peptide for hypoparathyroidism, produced robust
The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB61
TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”
EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteopor
Entera Bio (ENTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the
Entera Bio Ltd. (ENTX) Discusses Osteoporosis Treatment Landscape and Clinical Potential of EB613 Or
In a virtual Key Opinion Leader (KOL) roundtable hosted today, Entera Bio (Nasdaq: ENTX) convened gl
TEL AVIV, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- TEL AVIV, Israel, April 14, 2026 -- Entera Bio
MIAMI, April 6, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Israel-based En
TEL AVIV, Israel, April 02, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX) (“Entera” or the
U.S. stock futures up, focus on quarterly earnings of Americas Gold and Silver, ARKO Petroleum, Ente
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announ
Gainers
On Monday, 413 companies reached new 52-week lows.
During Wednesday's trading, 517 companies set new 52-week lows.
On Thursday, 930 stocks hit new 52-week lows.
Wednesday's session saw 361 companies set new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.
Before 10 a.m. ET on Friday, 571 companies hit new 52-week highs.
On Thursday morning, 420 companies hit new 52-week highs.
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
Stocks Which Set New 52-Week Low Friday, August 24th